Nissan Chemical (4021) AI Stock Analysis

• Market Cap: €640.49B
• Dividend Yield: 4.42%
• Average Volume (3M): 584.41K
• Price to Earnings (P/E): 15.0
• Beta (1Y): 0.68
• Revenue Growth: 10.88%
• EPS Growth: 14.80%
• Country: JP
• Employees: 3,137
• Sector: Basic Materials
• Sector Strength: 68
• Industry: Chemicals
• EPS (TTM): 82.99
• Shares Outstanding: 136,800,000
• 10 Day Avg. Volume: 730,200
• 30 Day Avg. Volume: 584,406
• PEG Ratio: -12.03
• Price to Book (P/B): 2.64
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 14.13
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €5,200.62
• Price Target Upside: 10.58% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 81 Outperform
• Price Target: ¥5,213.00 ▲(10.84%Upside)

Nissan Chemical achieves a strong overall stock score driven primarily by its robust financial performance and attractive valuation. The company's solid financials, characterized by low leverage and high profitability, support its growth prospects. The positive technical indicators suggest market confidence, although caution is advised due to the RSI nearing overbought levels. The lack of recent earnings call data and corporate events does not detract from the strong fundamentals and valuation of the stock.

Nissan Chemical Business Overview & Revenue Model

Company Description

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; OPTBEADS, a melamine-formaldehyde resin and silica; and FINEOXOCOL, a saturated fatty alcohol and acid. The company also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, it provides pharmaceutical products, such as LIVALO, a cholesterol reduction agent; LANDEL and FINTE, a dual type calcium antagonist that blocks calcium channels; and custom manufacturing and process researching services for pharmaceutical ingredients. Further, the company develops healthcare, information and communication materials, and environmental and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Nissan Chemical makes money through a multi-faceted revenue model driven by its diverse range of products and solutions. The company earns significant income from its chemical and performance materials divisions, which supply essential substances for various industrial applications, including electronics and automotive. The agricultural chemicals sector generates revenue through the sale of herbicides, insecticides, and fungicides that support global agricultural productivity. Additionally, the company benefits from its pharmaceuticals division by developing and licensing medical compounds and technologies. Strategic partnerships and collaborations with other corporations and research institutions also play a crucial role in enhancing its product offerings and expanding its market reach, thereby contributing to its overall earnings.

Nissan Chemical Financial Statement Overview

Summary

Nissan Chemical shows solid financial performance with strong revenue growth, high profitability, and a stable balance sheet. The low debt-to-equity ratio and high equity ratio indicate financial stability. Cash flow management is robust, although there's room for improvement in capital expenditure efficiency.

Income Statement

Nissan Chemical demonstrates strong financial performance with consistent revenue growth, evident from a 10.9% increase in revenue from 2024 to 2025. The company maintains high profitability, with a gross profit margin of 46.3% and a net profit margin of 17.1% in 2025. EBIT and EBITDA margins also reflect efficiency and profitability. These metrics highlight the company's robust revenue-generating capacity and cost management.

Balance Sheet

The balance sheet of Nissan Chemical shows a solid financial position with a low debt-to-equity ratio of 0.17, indicating conservative leverage. The equity ratio stands at 70.5%, signifying strong equity financing. Return on equity is also favorable at 18.4%, demonstrating effective utilization of shareholders' funds. These factors collectively suggest financial stability and a low-risk profile.

Cash Flow

Nissan Chemical exhibits healthy cash flow management, with a substantial free cash flow growth rate of 238.4% from 2024 to 2025. The operating cash flow to net income ratio of 1.38 indicates efficient cash conversion. However, the free cash flow to net income ratio is slightly lower at 1.00, indicating room for improvement in capital expenditures or operational efficiency.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	251.37B	226.71B	228.06B	207.97B	209.12B
Gross Profit	116.54B	104.78B	106.80B	101.09B	87.75B
EBITDA	74.55B	66.11B	63.26B	61.18B	52.95B
Net Income	43.04B	38.03B	41.09B	38.78B	33.47B
Balance Sheet
Total Assets	330.76B	323.46B	298.71B	279.69B	265.51B
Cash, Cash Equivalents and Short-Term Investments	27.45B	22.74B	29.65B	34.66B	32.38B
Total Debt	40.47B	40.98B	27.29B	22.71B	22.67B
Total Liabilities	94.58B	92.56B	77.19B	71.68B	64.95B
Stockholders Equity	233.29B	227.47B	218.42B	205.91B	198.83B
Cash Flow
Free Cash Flow	43.01B	12.70B	15.05B	29.10B	30.40B
Operating Cash Flow	59.18B	33.70B	35.23B	41.95B	39.94B
Investing Cash Flow	-17.61B	-18.74B	-19.64B	-12.39B	-12.85B
Financing Cash Flow	-35.65B	-22.10B	-25.03B	-27.87B	-25.63B

Nissan Chemical Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4703.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4021, the sentiment is Positive. The current price of 4703 is above the 20-day moving average (MA) of 4405.10, above the 50-day MA of 4308.18, and above the 200-day MA of 4596.65, indicating a bullish trend. The MACD of 95.18 indicates Negative momentum. The RSI at 73.37 is Negative, neither overbought nor oversold. The STOCH value of 89.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4021.

Nissan Chemical Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4021	81 Outperform	€640.49B	15.01	18.55%	4.42%	10.88%	14.80%
Sector *	44 Neutral	C$961.63M	-6.69	-13.73%	2.46%	17.55%	-32.57%
KURRF	―	$4.02B	28.00	2.92%	2.81%	―	―
MTLHF	―	$7.42B	25.06	2.49%	4.11%	―	―
SHWDF	―	$4.37B	17.85	6.01%	1.71%	―	―
SOMMF	―	$4.04B	17.78	3.96%	0.02%	―	―
TOSCF	―	$4.69B	12.29	7.04%	0.03%	―	―

Nissan Chemical Corporate Events

Nissan Chemical Announces Share Repurchase Program

Nissan Chemical Corporation has announced the repurchase of 320,000 of its own shares on the Tokyo Stock Exchange, amounting to a total purchase cost of 1,351,956,000 yen. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 2,500,000 shares, reflecting a commitment to enhancing shareholder value and optimizing capital structure.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5800.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Nissan Chemical Announces Share Repurchase Plan

Nissan Chemical Corporation has announced a decision by its Board of Directors to repurchase up to 2,500,000 of its own common shares, representing 1.84% of the total shares outstanding, excluding treasury shares. This move, with a total repurchase amount of up to 9 billion yen, aims to facilitate a flexible capital policy in response to the evolving business environment, potentially impacting the company’s market positioning and shareholder value.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.